Microba have partnered with US company Psomagen to deliver gut microbiome analysis technology to the US market.
We are innovating to help humanity achieve some of its most inspiring medical advancements in the 21st century. Read about Microba’s progress, partnership news and latest discoveries.
Machine learning technology will be used to identify significant associations between microorganisms and genes to predict different disease states.
Microba has backed sufferers of IBD through a donation to support IBD organisation Crohn’s and Colitis Australia.
Improved therapies for the long-term management of IBD are crucial and a currently unmet clinical need.
Microba has received a significant investment from global precision medicine company, Macrogen.
Microba has partnered with Macrogen to develop new microbiome services in offshore markets.
Microba has been named ‘Emerging Company of the Year’ in the AusBiotech and Johnson & Johnson Innovation Industry Excellence Awards.
Cloud infrastructure will be used to bolster Microba’s advanced gut microbiome research.